The survival rate of children with acute leukemia varies depending on the age of the child, the type of leukemia, and treatment. In general, the overall five-year survival rate for children with acute lymphocytic leukemia (ALL) is around 88%, with higher survival rates for younger children and lower rates for older adolescents. For acute myeloid leukemia (AML), the overall five-year survival rate is around 68%, with higher survival rates for younger children and lower rates for older adolescents.
Survival rates also vary depending on the type of leukemia. For ALL, the five-year survival rate for children aged 0-13 is around 93%, while for those aged 14-20 it is around 75%. For AML, the five-year survival rate for children aged 0-13 is around 75%, while for those aged 14-20 it is around 51%.
The type of treatment also affects the survival rate. For example, when treated with chemotherapy alone, the overall five-year survival rate for ALL is around 78%, and the overall five-year survival rate for AML is around 48%. When treated with a combination of chemotherapy and stem cell transplant, the overall five-year survival rate for ALL is around 92%, and the overall five-year survival rate for AML is around 72%.
It is important to note that survival rates may vary depending on a number of factors, including the child's overall health, the type and stage of the leukemia, and the type of treatment received. As such, it is important to speak with a healthcare provider for more information about the specific survival rate for a particular child.